Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (SYRS)

CUSIP: 87184Q206

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
27,196,692
Total 13F shares
12,136,541
Share change
+1,514,611
Total reported value
$47,926,746
Price per share
$3.95
Number of holders
47
Value change
+$6,035,294
Number of buys
16
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 87184Q206?
CUSIP 87184Q206 identifies SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (SYRS) as of Q3 2023

As of 30 Sep 2023, Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (SYRS) was held by 47 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,136,541 shares. The largest 10 holders included Bain Capital Life Sciences Investors, LLC, Avidity Partners Management LP, Artal Group S.A., CHI Advisors LLC, Flagship Pioneering Inc., Samsara BioCapital, LLC, Deep Track Capital, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, and DAFNA Capital Management LLC. This page lists 47 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.